ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q3 2020 | $11,000 | – | 259 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2018 | $12,000 | -25.0% | 136 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $16,000 | +100.0% | 136 | 0.0% | 0.00% | – |
Q1 2018 | $8,000 | 0.0% | 136 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | +33.3% | 136 | 0.0% | 0.00% | – |
Q3 2017 | $6,000 | +20.0% | 136 | 0.0% | 0.00% | – |
Q2 2017 | $5,000 | +25.0% | 136 | 0.0% | 0.00% | – |
Q1 2017 | $4,000 | -60.0% | 136 | -56.3% | 0.00% | – |
Q4 2016 | $10,000 | +100.0% | 311 | +77.7% | 0.00% | – |
Q3 2016 | $5,000 | -86.1% | 175 | -89.4% | 0.00% | -100.0% |
Q2 2016 | $36,000 | -36.8% | 1,651 | -3.7% | 0.00% | -50.0% |
Q4 2015 | $57,000 | – | 1,714 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |